(Q57998932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Synergistic enhancement of Toll-like receptor responses by NOD1 activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

Dominique Mengin-Lecreulx

31 December 2019

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Subrata Ghosh

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Matt Butler

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Karen Hunt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Brian Michael J Foxwell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Raymond J Playford

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

2471-2476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

NOD1 variation, immunoglobulin E and asthma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Role of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in h

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

hPepT1 transports muramyl dipeptide, activating NF-kappaB and stimulating IL-8 secretion in human colonic Caco2/bbe cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526296

7 January 2021

Identifiers

DOI

10.1002/EJI.200526296

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16021603%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference